Month: April 2022

ATHENS, Greece, April 11, 2022 (GLOBE NEWSWIRE) — Star Bulk (the “Company”) has today filed a new automatic shelf registration on Form F-3 in order to replace the existing shelf registration statement which would have expired on April 11, 2022. In connection with the filing of the new registration statement, the Company has entered into Amended and Restated ATM Sales Agreements with each of Deutsche Bank Securities Inc. and Jefferies LLC (“Jefferies”), each with substantially similar terms as the prior ATM Sales Agreements, which have been terminated. The filings being made today (the “Replacement Filings”) are solely due to the passage of time, and do not reflect any policy or strategy changes at Star Bulk. Due to technical difficulties with the Securities and Exchange Commission’s Electronic Data Gathering and Analysis...

WASHINGTON, April 11, 2022 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced that 31 professionals from the firm’s Corporate Finance & Restructuring, Forensic and Litigation Consulting and Technology segments have been named to the Who’s Who Legal: Investigations 2022 list. FTI Consulting had 21 experts recognized in the Forensic Accountants category and 10 professionals recognized in the Digital Forensic Experts category. In addition, five FTI Consulting professionals were named Future Leaders, individuals under 45 who were recognized as outstanding members of the next generation in their fields. Senior Managing Director Jordan Rae Kelly and Managing Directors Régis Pereira and Antonio Rega were honored as Future Leaders in Digital Forensics. Senior Managing Directors Tara Mulkeen and Wynand Mullins were...

PHILADELPHIA, April 11, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, announced that on April 4, 2022, the Company and Hunan Weitou Technology Co., Ltd. (“new investor”) have signed a legally binding equity investment totaling $15 Million which will be invested in five installments over the next 30 months. Under the terms of the agreement, the new investor will invest $3 Million at the beginning of every 6 months. The first $3 Million, which is in the form of private equity investment, has a purchase price at $0.414 per share. It is expected that the first investment installment will be completed in April 2022.   Dr. Ai-Dong Chen, Chairman of the board...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 11, 2022 (GLOBE NEWSWIRE) — Labrador Uranium Inc. (“LUR” or “Labrador Uranium”) (CSE: LUR) (F: EI1) is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc. to act as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase for resale 5,000,000 flow-through units of LUR to be sold to charitable purchasers (each, a “Charity FT Unit”) at a price of C$1.40 per Charity FT Unit (the “Unit Price”) on a “bought deal” private placement basis for gross proceeds of C$7,000,000 (the “Offering”). Each Charity FT Unit will consist of one common share of LUR to be issued as a “flow-through...

TORONTO, April 11, 2022 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a multi-year regional licensing agreement of subsidiary Transforming Systems (“TS”) SHREWD suite of solutions with NHS England and NHS Improvement Midlands (“NHSEI” or the “Customer”). This transaction marks a new customer sale for the Company, with TS having engaged with NHSEI since July 2021. The Customer, NHSEI, provides care for a population of 10.5 million people, across a very diverse and large region, including areas like Birmingham which is the UK’s second largest city, and Lincolnshire, which is the second largest English county in the country. The work of NHSEI involves supporting the 11 Integrated Care Systems (“ICSs”) and Sustainability and Transformation Plans (“STPs”), 42 trusts and 39 Clinical...

NEW YORK and BOSTON, April 11, 2022 (GLOBE NEWSWIRE) — Worlds Inc. (OTCQB: WDDD), a pioneer that developed the first 3D metaverses and technologies crucial to interactive online multi-player gaming technologies, today announces a partnership with CrossTower Inc., one of the world’s top rated cryptocurrency exchanges. Worlds will utilize CrossTower’s global non-fungible token (NFT) marketplace and services to sell NFTs of digital art, avatars, and other artifacts related to the first online interactive virtual worlds (now known as metaverses) created for some of the most famous music and entertainment artists and brands, such as Aerosmith, David Bowie, New York Yankees, DMC, WWE, and Coca-Cola. NFTs represent ownership of digital assets, including digital art, music, and gaming collectibles through blockchain technology. Consumers...

SANTA CLARA, Calif., April 11, 2022 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced the recipients of its 2022 Supplier Excellence Awards for contributions made to Applied’s business over the past year. The awards reflect outstanding technical and operational performance in several areas including quality, service, lead time, delivery, cost and responsiveness. “Having deep engagements throughout the supply chain is more critical than ever as we work together in new ways to address the current and future needs of the semiconductor industry,” said Dr. Gino Addiego, Senior Vice President of Semiconductor Global Operations and Corporate Quality at Applied Materials. “Applied thanks all its suppliers, particularly those receiving 2022 Supplier Excellence Awards, for their tremendous support and collaboration.” The following...

KNOXVILLE, TN, April 11, 2022 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that preclinical research on systemic administration of investigational cancer immunotherapy PV-10 (rose bengal sodium) for the treatment of high-risk and refractory adult solid tumor cancers is being presented at the annual meeting of the American Association for Cancer Research (AACR), being held April 8-13, 2022 in New Orleans, Louisiana. This PV-10 research has been led by Aru Narendran, MD, PhD and his team from the Cumming School of Medicine at the University of Calgary in Calgary, Alberta, Canada. Dr. Narendran and his colleagues previously showed that PV-10 induced cell death at pharmacologically-relevant concentrations in a panel of phenotypically-diverse adult solid tumor cell lines comprising breast, colorectal, head and neck, and...

– Ongoing experiments will evaluate the functionality and efficacy of the B7H3 TriKE in vivo– Future studies will also involve assessments of the B7H3 TriKE efficacy in the HNSCC tumor microenvironment BRISBANE, Calif., April 11, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (“the Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary tri-specific natural killer (NK) cell engager, TriKE® protein biologic technology platform, announced today that it is presenting pre-clinical data at the American Association For Cancer Research Annual Meeting 2022. The poster presentation titled, “#3435: GTB-5550 (cam16-IL15-camB7H3) Tri-specific Killer Engager (TriKE®) Drives NK Cell Activation and ADCC against Head and Neck Squamous Cell...